Soleus Capital Management, L.P.
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1802630
GREENWICH, CT
Position in INDV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$43,655,920
+$4,824,400 QoQ
Shares Held
1,064,000
-16.5% QoQ
Ownership
0.902%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#28
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $361,941,334 across 8 Drug Manufacturers - Specialty & Generic names. INDV ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
225,587 | $122,229,804 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
867,760 | $71,833,172 | |
| 3 | ALKS |
Alkermes plc.
|
1,029,252 | $53,932,804 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
1,064,000 | $43,655,920 | |
| 5 | ORGO |
Organogenesis Holdings Inc.
|
10,140,951 | $24,642,510 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
520,000 | $24,185,200 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
246,353 | $15,754,274 | |
| 8 | EOLS |
Evolus, Inc.
|
822,428 | $5,707,650 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,655,920 | 1,064,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $38,831,520 | 1,274,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||